News | Nuclear Imaging | March 03, 2022

The Society of Nuclear Medicine and Molecular Imaging posted this statement on its website regarding the current situation in Ukraine

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

March 3, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

SNMMI’s mission is to improve human health by advancing nuclear medicine, molecular imaging and radionuclide therapy. Given our global scope, SNMMI leadership must express its grave concern about the rapidly deteriorating situation in Ukraine. Many more lives will be lost in the coming days and weeks unless a peaceful resolution of this conflict is rapidly secured. In addition, Ukraine has 15 nuclear reactors providing half the power to the country and houses the Chernobyl nuclear facility, which requires intensive environmental management for safety purposes. Among the civilians threatened by this invasion are the workers who keep these nuclear power plants and the Chernobyl nuclear facility safe.

For these nuclear workers, for the healthcare professionals delivering nuclear medicine and other services, and most importantly, for the safety and welfare of the Ukrainian people, SNMMI urges an immediate cessation of the invasion and occupation of Ukraine and strongly supports a rapid and peaceful resolution of this conflict.

Our thoughts are with all those affected by this crisis in the Ukraine and around the world.

For more information: www.snmmi.org


Related Content

News | Breast Imaging

May 25, 2023 — GE HealthCare, a leader in breast cancer care technology and diagnostics, has today announced that NCCN ...

Time May 25, 2023
arrow
News | Radiation Oncology

May 16, 2023 — The American Society for Radiation Oncology (ASTRO) today expressed its strong support for President ...

Time May 16, 2023
arrow
News | Contrast Media

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
News | Contrast Media

May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced that ...

Time May 15, 2023
arrow
News | PET Imaging

May 12, 2023 — A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or ...

Time May 12, 2023
arrow
News | Prostate Cancer

May 2, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 02, 2023
arrow
News | Radiation Therapy

May 1, 2023 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage ...

Time May 01, 2023
arrow
News | PET Imaging

April 28, 2023 — GE HealthCare to deliver two Cyclotrons next year, expanding South Africa’s capacity to produce ...

Time April 28, 2023
arrow
News | Radiopharmaceuticals and Tracers

April 24, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 24, 2023
arrow
News | Molecular Imaging

April 13, 2023 —NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 13, 2023
arrow
Subscribe Now